Market Overview:
The global oral electrolyte solutions market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of dehydration, especially among infants and children, due to diarrhea and vomiting. In addition, the growing awareness about the benefits of oral electrolyte solutions is also contributing to the growth of this market. The global oral electrolyte solutions market can be segmented on the basis of type into lemonadex, orange, and other types. The lemonadex segment is expected to account for a major share in terms of revenue in 2018 owing to its high demand among consumers across all age groups. On the basis of application, this market can be divided into infants, children, and adults. The infants segment is projected to register highest CAGR during 2018-2030 owing rising incidences rates dehydration cases globally .Geographically ,the global oral electrolytes solutionmarket has been classified into North America , Latin America Europe Asia Pacificand Middle East & Africa .
Product Definition:
An oral electrolyte solution is a drink that contains water, sugar, salt and minerals. It is used to replace lost fluids and minerals when you have diarrhea or vomiting.
Lemonadex:
Lemonadex is a prescription drug that belongs to the class of drugs known as antidiarrheal medicines. It's main active ingredient is dextrose in water, which helps in preventing and relieving diarrhea. Lemonadex works by stimulating cells that produce stomach fluids and slowing down the movement of food through the digestive tract.
Orange:
The orange is a rich source of vitamin C and carotene. It also contains sugar, which makes it sweet and edible. The fruit has thin skin which easily gets damaged. Hence the fruits are processed by removing the skin with the help of centrifugal force or freezing technique to obtain juice or pulp for further use in food preparation. Orange juice is used as an ingredient for preparing different types of beverages such as cocktails, sodas, tonic water etc.
Application Insights:
Based on the application, the global oral electrolyte solutions market is segmented into infants, children and adults. The infant segment held a major share in 2017 owing to increasing prevalence of diarrhea among infants globally. According to WHO, more than 1 billion people suffer from diarrhea every year and around half of them are under 5 years of age. In addition, growing awareness about hygiene is expected to drive demand for oral care products such as mouthwash among infants in developing countries like India and China over the forecast period.
The adult segment is expected to witness significant growth over the forecast period due to rising geriatric population across developed countries including Germany, Japan U.K.
Regional Analysis:
Asia Pacific dominated the global market in 2017. The presence of a large number of patients suffering from chronic diseases, increasing geriatric population, and rising awareness about nutritional products are some major factors driving the regional demand. In addition, growing medical tourism in emerging countries such as India and China is expected to fuel industry growth over the forecast period.
Europe accounted for a significant share owing to high prevalence of kidney disorders coupled with rising healthcare expenditure by government agencies such as National Health Services (NHS) in U.K., social security system in Germany among others that promote access to healthcare services for people living outside Europe at low cost which benefits end-users’ profitability margins positively influencing overall market growth.
Growth Factors:
- Increasing geriatric population: The global geriatric population is increasing at a rapid pace and this is expected to drive the demand for oral electrolyte solutions in the coming years.
- Growing awareness about the benefits of oral electrolyte solutions: There is a growing awareness among people about the benefits of using oral electrolyte solutions, which is likely to boost demand for these products in the near future.
- Rising incidence of dehydration: Dehydration is a common problem that can occur due to various reasons such as diarrhea, vomiting, and excessive sweating. This has led to an increase in demand for oral electrolyte solutions worldwide.
- Technological advancements: Oral electrolyte solution manufacturers are constantly innovating their products with new technologies and formulations that offer better results and user experience. This is likely to fuel market growth in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Oral Electrolyte Solutions Market Research Report
By Type
Lemonadex, Orange, Other
By Application
Infants, Children, Adults
By Companies
Abbott, Mead Johnson, Sanofi, DripDrop Inc., Pendopharm, Johnson & Johnson, Jiangsu Hengrui Medicine, Otsuka Pharmaceutical Factory, Shanghai Trifecta Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
244
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Oral Electrolyte Solutions Market Report Segments:
The global Oral Electrolyte Solutions market is segmented on the basis of:
Types
Lemonadex, Orange, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Infants, Children, Adults
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Mead Johnson
- Sanofi
- DripDrop Inc.
- Pendopharm
- Johnson & Johnson
- Jiangsu Hengrui Medicine
- Otsuka Pharmaceutical Factory
- Shanghai Trifecta Pharma
Highlights of The Oral Electrolyte Solutions Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Lemonadex
- Orange
- Other
- By Application:
- Infants
- Children
- Adults
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Oral Electrolyte Solutions Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Oral electrolyte solutions are a type of oral health care product that help to replace lost minerals and fluids in the mouth. Oral electrolyte solutions are available as drops, tablets, or syrups and can be used to treat a variety of conditions, such as dry mouth or toothache.
Some of the key players operating in the oral electrolyte solutions market are Abbott, Mead Johnson, Sanofi, DripDrop Inc., Pendopharm, Johnson & Johnson, Jiangsu Hengrui Medicine, Otsuka Pharmaceutical Factory, Shanghai Trifecta Pharma.
The oral electrolyte solutions market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Oral Electrolyte Solutions Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Oral Electrolyte Solutions Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Oral Electrolyte Solutions Market - Supply Chain
4.5. Global Oral Electrolyte Solutions Market Forecast
4.5.1. Oral Electrolyte Solutions Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Oral Electrolyte Solutions Market Size (000 Units) and Y-o-Y Growth
4.5.3. Oral Electrolyte Solutions Market Absolute $ Opportunity
5. Global Oral Electrolyte Solutions Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Oral Electrolyte Solutions Market Size and Volume Forecast by Type
5.3.1. Lemonadex
5.3.2. Orange
5.3.3. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Oral Electrolyte Solutions Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Oral Electrolyte Solutions Market Size and Volume Forecast by Application
6.3.1. Infants
6.3.2. Children
6.3.3. Adults
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Oral Electrolyte Solutions Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Oral Electrolyte Solutions Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Oral Electrolyte Solutions Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Oral Electrolyte Solutions Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Oral Electrolyte Solutions Demand Share Forecast, 2019-2026
9. North America Oral Electrolyte Solutions Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Oral Electrolyte Solutions Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Oral Electrolyte Solutions Market Size and Volume Forecast by Application
9.4.1. Infants
9.4.2. Children
9.4.3. Adults
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Oral Electrolyte Solutions Market Size and Volume Forecast by Type
9.7.1. Lemonadex
9.7.2. Orange
9.7.3. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Oral Electrolyte Solutions Demand Share Forecast, 2019-2026
10. Latin America Oral Electrolyte Solutions Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Oral Electrolyte Solutions Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Oral Electrolyte Solutions Market Size and Volume Forecast by Application
10.4.1. Infants
10.4.2. Children
10.4.3. Adults
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Oral Electrolyte Solutions Market Size and Volume Forecast by Type
10.7.1. Lemonadex
10.7.2. Orange
10.7.3. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Oral Electrolyte Solutions Demand Share Forecast, 2019-2026
11. Europe Oral Electrolyte Solutions Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Oral Electrolyte Solutions Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Oral Electrolyte Solutions Market Size and Volume Forecast by Application
11.4.1. Infants
11.4.2. Children
11.4.3. Adults
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Oral Electrolyte Solutions Market Size and Volume Forecast by Type
11.7.1. Lemonadex
11.7.2. Orange
11.7.3. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projecions by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Oral Electrolyte Solutions Demand Share, 2019-2026
12. Asia Pacific Oral Electrolyte Solutions Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Oral Electrolyte Solutions Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Oral Electrolyte Solutions Market Size and Volume Forecast by Application
12.4.1. Infants
12.4.2. Children
12.4.3. Adults
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Oral Electrolyte Solutions Market Size and Volume Forecast by Type
12.7.1. Lemonadex
12.7.2. Orange
12.7.3. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Oral Electrolyte Solutions Demand Share, 2019-2026
13. Middle East & Africa Oral Electrolyte Solutions Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Oral Electrolyte Solutions Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Oral Electrolyte Solutions Market Size and Volume Forecast by Application
13.4.1. Infants
13.4.2. Children
13.4.3. Adults
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Oral Electrolyte Solutions Market Size and Volume Forecast by Type
13.7.1. Lemonadex
13.7.2. Orange
13.7.3. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Oral Electrolyte Solutions Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Oral Electrolyte Solutions Market: Market Share Analysis
14.2. Oral Electrolyte Solutions Distributors and Customers
14.3. Oral Electrolyte Solutions Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Mead Johnson
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Sanofi
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. DripDrop Inc.
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Pendopharm
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Johnson & Johnson
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Jiangsu Hengrui Medicine
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Otsuka Pharmaceutical Factory
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Shanghai Trifecta Pharma
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook